Literature DB >> 8970688

Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study.

M L Newell1, D T Dunn, C S Peckham, A E Semprini, G Pardi.   

Abstract

OBJECTIVE: To estimate the effect of maternal factors and events around the time of delivery on HIV-1 vertical transmission risk.
DESIGN: Prospective study.
SETTING: Twenty-two obstetric and paediatric clinics in seven European countries. PATIENTS OR OTHER PARTICIPANTS: Mothers identified as HIV-infected before or at delivery and their children. MAIN OUTCOME MEASURE: Paediatric HIV infection.
RESULTS: By November 1995, 1846 mothers with 1945 children had been enrolled. The vertical transmission rate was 16.4% (95% confidence interval, 14.5-18.3). Parity, maternal age, race, mode of HIV acquisition, injecting drug use and sex of infant were not statistically significantly associated with risk of transmission. Children delivered vaginally were more likely to be infected than those delivered by Caesarean section. However, in vaginal deliveries the procedures used, duration of ruptured membranes or length of second-stage labour were not related to transmission. Transmission increased almost linearly with decreasing CD4 cell count, but there was no such trend for CD8 cell count. Women with CD4 cell counts below 200 x 10(6)/l were significantly more likely to deliver early (chi 2 for trend, 14.02; P < 0.001). Very premature infants were at increased risk of infection, but after about 35 weeks gestation the transmission rate remained stable, with no increase in late pregnancy. This trend was confirmed after allowing for maternal CD4 cell count.
CONCLUSIONS: The rate of vertical transmission increases linearly with decreasing maternal CD4 cell count. Women with fewer than 200 x 10(6) CD4 cells/l have an increased risk of premature delivery, which would affect timing of interventions. The stable transmission rate after 35 weeks gestation suggests little acquisition of infection during late pregnancy.

Entities:  

Mesh:

Year:  1996        PMID: 8970688

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  15 in total

Review 1.  Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.

Authors:  Marcus Altfeld; Madeleine J Bunders
Journal:  Semin Immunopathol       Date:  2016-07-08       Impact factor: 9.623

Review 2.  Perinatal transmission of HIV and diagnosis of HIV infection in infants: a review.

Authors:  C B Nourse; K M Butler
Journal:  Ir J Med Sci       Date:  1998 Jan-Mar       Impact factor: 1.568

3.  Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

Authors:  Kunjal Patel; David E Shapiro; Susan B Brogly; Elizabeth G Livingston; Alice M Stek; Arlene D Bardeguez; Ruth E Tuomala
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

4.  Acceptability of perinatal rapid point-of-care HIV testing in an area of low HIV prevalence in the UK.

Authors:  Suzy H M Stokes; Paddy McMaster; Khaled M K Ismail
Journal:  Arch Dis Child       Date:  2007-02-09       Impact factor: 3.791

5.  Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples.

Authors:  H Blaak; A B van't Wout; M Brouwer; M Cornelissen; N A Kootstra; N Albrecht-van Lent; R P Keet; J Goudsmit; R A Coutinho; H Schuitemaker
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 6.  Advances and failures in preventing perinatal human immunodeficiency virus infection.

Authors:  Ann M Buchanan; Coleen K Cunningham
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

7.  Cost-effectiveness of Childbirth Strategies for Prevention of Mother-to-child Transmission of HIV Among Mothers Receiving Nevirapine in India.

Authors:  Kanchan Mukherjee
Journal:  Indian J Community Med       Date:  2010-01

8.  Mother-to-child transmission of human immunodeficiency virus (HIV) in Ireland: a prospective study.

Authors:  C B Nourse; T Conlon; E Hayes; G Kaminski; E Griffin; I Hillary; K M Butler
Journal:  Ir J Med Sci       Date:  1998 Jul-Sep       Impact factor: 1.568

9.  Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy.

Authors:  M Floridia; M Ravizza; E Tamburrini; G Anzidei; C Tibaldi; A Maccabruni; G Guaraldi; S Alberico; A Vimercati; A Degli Antoni; E Ferrazzi
Journal:  Epidemiol Infect       Date:  2006-03-02       Impact factor: 2.451

10.  Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy.

Authors:  Allan W Taylor; Barudi Mosimaneotsile; Unami Mathebula; Anikie Mathoma; Ritah Moathlodi; Irene Theebetsile; Taraz Samandari
Journal:  Infect Dis Obstet Gynecol       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.